| |
|
|
|
Kazia Therapeutics Ltd  
|
|
6.09 0.14 (0.02%) |
10-21 16:00 |
|
Open: |
6.045 |
Pre close: |
5.95 |
Target:
|
7.63 
|
|
High: |
6.19 |
Low: |
6.025 |
Resistance:
|
6.54
7.09
|
|
Volume: |
12,761 |
Market Cap: |
67M |
Support:
|
5.64
4.69
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.88
 |
MACD |
MACD(12,26):
|
-0.19 |
|
MA(20): |
6.22 |
Signal(12,26,9): |
-0.17 |
|
MA(100): |
5.19 |
Stochastic Oscillator |
%K(14,3):
|
25.83 |
|
MA(250): |
4.28 |
%D(3): |
14.17 |
|
Average Volume(K) |
3-Month: |
61685
|
52-Week |
High:
|
9.74 |
|
10-Days: |
5551 |
Low: |
2.47 |
|
RSI |
RSI(14):
|
45.55 |
Change(%): |
86.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.920 |
Return on Equity (ttm) |
-88.1 |
Shares Out. (M) |
7.53 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-34.5 |
Shares Float (M) |
5.78 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-46.1 |
% Held by Institutions |
3.56 |
|
Forward EPS |
-1.258 |
Gross Profit (p.s.) |
0.131 |
Shares Short (K) |
30 |
|
Book Value (p.s.) |
2.940 |
EBITDA (p.s.) |
0.000 |
P/E |
-6.62 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.07 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
